跳至主要内容
临床试验/NCT01981876
NCT01981876已完成不适用

Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital

Tenwek Hospital1 个研究点 分布在 1 个国家目标入组 305 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
305
试验地点
1
主要终点
Percentage rate of subjects with Esophageal Squamous dysplasia calculated as Prevalence

研究概览

简要总结

Esophageal squamous cell cancer (ESCC) is common in the developing world, and is the leading cancer diagnosis at Tenwek Hospital in southwestern Kenya. The investigators long-term goal is to understand the pathogenesis and risk factors for ESCC in Kenya, and to establish effective screening and prevention programs. The investigators hypothesize that asymptomatic esophageal squamous dysplasia (ESD) is common in their region, and the current protocol is designed to determine the prevalence of ESD in residents of southwestern Kenya.

详细描述

The prevalence of esophageal squamous dysplasia will be determined after evaluating pathology reports from unstained lesions and normal biopsies after staining with Lugol's iodine.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 20 years
  • No dysphagia (subjects will be asked "do you have trouble swallowing food or water? Do they get stuck inside after you swallow?" in their primary language

排除标准

  • Cardiac, respiratory, or metabolic disease that would increase the risk of endoscopy: history of myocardial infarction, arrhythmias, chronic obstructive pulmonary disease, diabetes, allergy to lidocaine.
  • Unable or unwilling to provide informed consent.

结局指标

主要结局

Percentage rate of subjects with Esophageal Squamous dysplasia calculated as Prevalence

时间窗: 2 years

次要结局

  • percentage of subjects with mild esophageal squamous dysplasia calculated as a prevalence(2 years)
  • percentage of subjects with severe esophageal squamous dysplasia calculated as a prevalence(2 years)
  • percentage of subjects with moderate esophageal squamous dysplasia calculated as a prevalence(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验